Welcome to the 3rd annual +Dx Diagnostics Forum, McDermott+Consulting's premier diagnostics conference. The diagnostic industry is in the midst of significant transformation. PAMA reporting is imminent, as are the Medicare payment changes that will follow. The US Food and Drug Administration’s LDT guidance is still anticipated, despite recent agency announcements, and all this will occur under the umbrella of a new Administration and Republican Congress.
+Dx will tackle these important issues with a refreshed and energized agenda, featuring not only the comprehensive overview of pending pertinent regulatory and reimbursement issues that attendees have come to appreciate, but also new topics and speakers, including a look into the new adiminstration's health care priorities. Our faculty will provide in-depth analysis, thoughtful guidance and strategic insights into industry changes and the shifting Washington landscape.
Check back soon for a finalized agenda and faculty list.
Paul W. Radensky, M.D.
Principal and Program Chair
Thursday, April 6, 2016
8:00 AM - 4:30 PM EDT - Forum (tentative)
Networking Cocktail Reception to follow
The McDermott Building500 North Capitol Street, NWWashington, District of Columbia 20001USA+1 202 204 1450